A prospective cohort study across four countries to identify factors that predict the performance of the 3M Coban 2 Compression System (Coban 2 system) and Standard Compression used within Decongestive Lymphatic Therapy in patients with lymphoedema.
The aim of the study is to gain further clinical experience on the effectiveness of the Coban 2 system in the treatment of patients with lymphoedematous legs and arms and to determine the factors that predict limb volume reduction over a period of up to 28 days intensive therapy. In addition a cohort of patients will use Best Practice (without the Coban 2 system) to determine similar factors. A comparison will be made between the two groups to determine the outcome of treatment for the two cohorts.
The principal analysis will compare the percentage limb volume reduction over the intensive phase of treatment and observe changes in limb volume during the maintenance phase of treatment.